Company: XOMAP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001558370-25-011305
Chunk: 4

Company: XOMA Royalty Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1C
Chunk 4
---
1,368​​ 1,368Current portion of long-term debt​​ 11,672​​ 11,394Total current liabilities​  21,495​  24,374Unearned revenue recognized under units-of-revenue method – long-term​  3,666​  4,410Exarafenib milestone contingent consideration (Note 4)​​ 3,402​​ 3,214Long-term operating lease liabilities​​ 238​​ 483Long-term debt​​ 102,201​​ 106,875Total liabilities​  131,002​  139,356​​​​​​​Commitments and Contingencies (Note 10)​​​​​​​​​​​​​Convertible preferred stock, $0.05 par value, 5,003 shares authorized, issued and outstanding as of June 30, 2025 and December 31, 2024​  20,019​  20,019​​​​​​​Stockholders’ equity:​​​​​​8.625% Series A cumulative, perpetual preferred stock, $0.05 par value, 984,000 shares authorized, issued and outstanding as of June 30, 2025 and December 31, 2024​​ 49​​ 498.375% Series B cumulative, perpetual preferred stock, $0.05 par value, 3,600 shares authorized, 1,600 shares issued and outstanding as of June 30, 2025 and December 31, 2024​​ —​  —Common stock, $0.0075 par value, 277,333,332 shares authorized, 12,062,466 and 11,952,377 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively​  90​  90Additional paid-in capital​  1,300,066​  1,298,747Accumulated other comprehensive income​​ 122​​ 73Accumulated deficit​  (1,227,892)​  (1,237,057)Total stockholders’ equity​  72,435​  61,902Total liabilities, convertible preferred stock and stockholders’ equity​$ 223,456​$ 221,277

​

The accompanying notes are an integral part of these condensed consolidated financial statements.